Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: ImmunoPET Imaging of Pancreatic Cancer [NA]
A clinical trial update indicates an ImmunoPET imaging study for pancreatic cancer is currently recruiting at RenJi Hospital.
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: PET-imaging of Two Vartumabs in Patients With Solid Tumors [EARLY_Phase 1]
This early-phase PET-imaging trial evaluates two vartumabs in patients with solid tumors and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/2 study of a KRAS G12V-specific T cell receptor-transduced T cell therapy for advanced pancreat…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Tunlametinib + AG + Cetuximab β as First-Line Therapy for Advanced Pancreatic Cancer [Phase 4]
Phase 4 trial planned to evaluate tunlametinib plus AG and Cetuximab beta as first-line therapy for advanced non-resectable pancreatic cance…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors
A clinical trial is evaluating PET imaging targeting CLDN18.2 for detecting malignant tumors, with recruitment ongoing in gastric cancer, pa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma [Phase 2]
This update describes an ongoing Phase II clinical trial at Yale evaluating a modified FOLFIRINOX chemotherapy regimen together with stereot…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: A Study of GC203 TIL in PDCA (RJ) [EARLY_Phase 1]
Phase 1 study evaluating GC203 TIL therapy for pancreatic cancer, including pancreatic ductal adenocarcinoma. The trial is currently recruit…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Acupuncture for the Management of Postoperative Pain in Patients With Pancreatic or Colorectal Cancer Undergoing Surgery [NA]
An update on a clinical trial evaluating acupuncture to manage postoperative pain in patients with pancreatic or colorectal cancer undergoin…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors [Phase 1]
A Phase 1 study evaluating PT0511 in adults with KRAS-mutated or amplified advanced solid tumors, including colorectal cancer, pancreatic ca…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas [Phase 2]
A Phase 2 clinical trial update describes a program for in-home cancer treatment with remote expert support, currently recruiting for patien…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trial evaluating Ivaltinostat with Capecitabine (or Capecitabine alone) for metastatic pancreatic adenocarcinoma;…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Whether Control of Serum Uric Acid (SUA) Improves Survival After Pancreatic Cancer
This clinical trial investigates whether controlling serum uric acid improves survival after pancreatic cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Pancreatic Cancer Detection Consortium
This Clinical Trial Update describes the Pancreatic Cancer Detection Consortium sponsored by City of Hope Medical Center, currently recruiti…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers [Phase 1]
Phase 1 clinical trial evaluating Palliadelic treatment to reduce psychological distress in people with advanced pancreatic and biliary trac…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: RCT of Mobile Apps & FitBit v. Usual Care [NA]
An ongoing randomized trial compares a mobile apps plus FitBit intervention to usual care in patients with pancreatic, gastric, liver, colon…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Clinical trial update for TST001 in advanced or metastatic solid tumors (Phase 1/2); the study is currently active and not recruiting.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib [Phase 2]
An open-label Phase 2 extension study to enable continued access to ruxolitinib for subjects previously enrolled in ruxolitinib trials.
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating telotristat ethyl for weight stability in advanced pancreatic cancer has completed with results posted.
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis [Phase 2]
Phase 2 clinical trial investigating hyperthermic intraperitoneal chemotherapy (HIPEC) for metastatic pancreatic cancer with peritoneal meta…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC) [Phase 1, Phase 2]
A clinical trial update indicates that Tumor Treating Fields (TTFields) combined with chemotherapy is being studied in metastatic pancreatic…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Paravertebral Block vs no Block in Open Pancreaticoduodenectomy [Phase 4]
A Phase 4 trial comparing paravertebral block to no block in open pancreaticoduodenectomy was terminated; results have been posted.
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care [NA]
This Clinical Trials update describes GENOCARE, a prospective randomized study comparing genotype-guided dosing to usual care in colorectal …
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related Diabetes [Phase 3]
A Phase 3 trial evaluating adding active anti-diabetic therapy to chemotherapy for pancreatic cancer-related diabetes, sponsored by Fudan Un…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]
This document provides a Phase 2 clinical trial update comparing combination immunotherapy plus standard-of-care chemotherapy to standard ch…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab [Phase 1, Phase 2]
Ongoing Phase 1/2 trial evaluating the combination of pelareorep and atezolizumab in advanced anal cancer and pancreatic cancer.